论文部分内容阅读
一、加入WTO后我国医药产业面临的挑战与对策医药产业具有重大的社会效益和经济效益。我国有13亿人口,迄今仍有许多严重威胁人民生命健康的疾病缺乏有效的防治药物。针对这些重要疾病,不断研究和创制新的优良药物,是我国人口健康领域的紧迫需求。不仅如此,医药工业又是一项高新技术密集的产业,它的发展将带来极为巨大的经济效益。随着全世界的经济发展和社会进步,人类对保健、治病的要求越来越高,医药产业将会有更大的发展,前景十分广阔。可以预见,我国现代医药产业在整个国民经济中所占的比重将会有很大的提高,现代医药产业将成为我国二十一世纪的支柱产业和新的经济增长点之一。
I. Challenges and Countermeasures Faced by China’s Pharmaceutical Industry after China’s Entry into WTO The pharmaceutical industry has major social and economic benefits. China has a population of 1.3 billion. There are still many serious diseases that threaten people’s life and health. There is no effective anti-drug medicine. In view of these important diseases, continuous research and creation of new and excellent drugs are urgent needs in the population health field in China. Not only that, the pharmaceutical industry is also a high-tech intensive industry, and its development will bring enormous economic benefits. With the development of the world economy and social progress, human beings have higher and higher requirements for health care and treatment. The pharmaceutical industry will have greater development and the prospects are very broad. It can be foreseen that the proportion of China’s modern pharmaceutical industry in the entire national economy will be greatly improved, and the modern pharmaceutical industry will become one of China’s pillar industries and new economic growth points in the 21st century.